Loading…
Olfactory mucosa stem cells delivery via nasal route: a simple way for the treatment of Parkinson disease
Finding a simple and effective way for transferring cells to the brain lesion site with minimum side effects mounts a challenge in cell therapy. Cell delivery via nasal route using the bypassing the blood-brain barrier (BBB) property is a simple and non-invasive strategy without serious complication...
Saved in:
Published in: | Neurotoxicity research 2021-06, Vol.39 (3), p.598-608 |
---|---|
Main Authors: | , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c347t-273f6aea0e27b9bc764c69f477e28d3f8019ffe2049c402fe1143f7207f96c1d3 |
---|---|
cites | cdi_FETCH-LOGICAL-c347t-273f6aea0e27b9bc764c69f477e28d3f8019ffe2049c402fe1143f7207f96c1d3 |
container_end_page | 608 |
container_issue | 3 |
container_start_page | 598 |
container_title | Neurotoxicity research |
container_volume | 39 |
creator | Simorgh, Sara Alizadeh, Rafieh Shabani, Ronk Karimzadeh, Fariba Seidkhani, Elham Majidpoor, Jamal Moradi, Fatemeh Kasbiyan, Hamidreza |
description | Finding a simple and effective way for transferring cells to the brain lesion site with minimum side effects mounts a challenge in cell therapy. Cell delivery via nasal route using the bypassing the blood-brain barrier (BBB) property is a simple and non-invasive strategy without serious complications such as trauma. Therefore, it is a suitable technique to treat neurodegenerative disorders like Parkinson’s disease (PD). Olfactory ectomesenchymal stem cells (OE-MSCs) located in the lamina propria of olfactory mucosa could be differentiated into dopaminergic neurons under
in vitro
and
in vivo
conditions. Thus, OE-MSCs represent a good source of Parkinson’s stem cell–based therapy. In this research, we studied thirty male rats (
n
= 10 in each group) in three control (Ctl), lesion (LE), and intranasal administration (INA) groups to investigate the therapeutic effect of intranasal injection of OE-MSCs in the Parkinson’s animal models. To do so, we examined the homing variation of OE-MSCs in different brain regions such as olfactory bulb (OB), cortex, striatum (Str), hippocampus (HPC), and substantia nigra (SN). The results of real-time PCR and immunohistochemistry (IHC) analysis showed the expression of dopaminergic neuron markers such as PITX3, PAX2, PAX5 (as dopaminergic neurons markers), tyrosine hydroxylase (TH), and dopamine transporter (DAT) 2 months after INA of 1 × 10
6
OE-MSCs. The results confirmed that IN OE-MSCs delivery into the central nervous system (CNS) was powerful enough to improve the behavioral functions in the animal models of PD.
Graphical Abstract |
doi_str_mv | 10.1007/s12640-020-00290-1 |
format | article |
fullrecord | <record><control><sourceid>pubmed_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1007_s12640_020_00290_1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>33433781</sourcerecordid><originalsourceid>FETCH-LOGICAL-c347t-273f6aea0e27b9bc764c69f477e28d3f8019ffe2049c402fe1143f7207f96c1d3</originalsourceid><addsrcrecordid>eNp9kMtOwzAQRS0EoqXwAyyQfyDgV-2EHap4SZXKAtaW64whJYkr2ynq32MIsGQxmtHMvVeag9A5JZeUEHUVKZOCFITlIqwiBT1AUyqULPicicM8521RClZO0EmMmyyic6mO0YRzwbkq6RQ1q9YZm3zY426wPhocE3TYQttGXEPb7CCfdo3BvYmmxcEPCa5xljXdtgX8YfbY-YDTG-AUwKQO-oS9w08mvDd99D2umwgmwik6cqaNcPbTZ-jl7vZ58VAsV_ePi5tlYblQqWCKO2nAEGBqXa2tksLKygmlgJU1dyWhlXPAiKisIMwBpYI7xYhylbS05jPExlwbfIwBnN6GpjNhrynRX9z0yE1nbvqbm6bZdDGatsO6g_rP8gsqC_goiPnUv0LQGz-EPj_yX-wnvpB5rA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Olfactory mucosa stem cells delivery via nasal route: a simple way for the treatment of Parkinson disease</title><source>Springer Nature</source><creator>Simorgh, Sara ; Alizadeh, Rafieh ; Shabani, Ronk ; Karimzadeh, Fariba ; Seidkhani, Elham ; Majidpoor, Jamal ; Moradi, Fatemeh ; Kasbiyan, Hamidreza</creator><creatorcontrib>Simorgh, Sara ; Alizadeh, Rafieh ; Shabani, Ronk ; Karimzadeh, Fariba ; Seidkhani, Elham ; Majidpoor, Jamal ; Moradi, Fatemeh ; Kasbiyan, Hamidreza</creatorcontrib><description>Finding a simple and effective way for transferring cells to the brain lesion site with minimum side effects mounts a challenge in cell therapy. Cell delivery via nasal route using the bypassing the blood-brain barrier (BBB) property is a simple and non-invasive strategy without serious complications such as trauma. Therefore, it is a suitable technique to treat neurodegenerative disorders like Parkinson’s disease (PD). Olfactory ectomesenchymal stem cells (OE-MSCs) located in the lamina propria of olfactory mucosa could be differentiated into dopaminergic neurons under
in vitro
and
in vivo
conditions. Thus, OE-MSCs represent a good source of Parkinson’s stem cell–based therapy. In this research, we studied thirty male rats (
n
= 10 in each group) in three control (Ctl), lesion (LE), and intranasal administration (INA) groups to investigate the therapeutic effect of intranasal injection of OE-MSCs in the Parkinson’s animal models. To do so, we examined the homing variation of OE-MSCs in different brain regions such as olfactory bulb (OB), cortex, striatum (Str), hippocampus (HPC), and substantia nigra (SN). The results of real-time PCR and immunohistochemistry (IHC) analysis showed the expression of dopaminergic neuron markers such as PITX3, PAX2, PAX5 (as dopaminergic neurons markers), tyrosine hydroxylase (TH), and dopamine transporter (DAT) 2 months after INA of 1 × 10
6
OE-MSCs. The results confirmed that IN OE-MSCs delivery into the central nervous system (CNS) was powerful enough to improve the behavioral functions in the animal models of PD.
Graphical Abstract</description><identifier>ISSN: 1029-8428</identifier><identifier>EISSN: 1476-3524</identifier><identifier>DOI: 10.1007/s12640-020-00290-1</identifier><identifier>PMID: 33433781</identifier><language>eng</language><publisher>New York: Springer US</publisher><subject>Biomedical and Life Sciences ; Biomedicine ; Cell Biology ; Neurobiology ; Neurochemistry ; Neurology ; Neurosciences ; Original Article ; Pharmacology/Toxicology</subject><ispartof>Neurotoxicity research, 2021-06, Vol.39 (3), p.598-608</ispartof><rights>Springer Science+Business Media, LLC, part of Springer Nature 2021</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c347t-273f6aea0e27b9bc764c69f477e28d3f8019ffe2049c402fe1143f7207f96c1d3</citedby><cites>FETCH-LOGICAL-c347t-273f6aea0e27b9bc764c69f477e28d3f8019ffe2049c402fe1143f7207f96c1d3</cites><orcidid>0000-0001-9231-280X</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33433781$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Simorgh, Sara</creatorcontrib><creatorcontrib>Alizadeh, Rafieh</creatorcontrib><creatorcontrib>Shabani, Ronk</creatorcontrib><creatorcontrib>Karimzadeh, Fariba</creatorcontrib><creatorcontrib>Seidkhani, Elham</creatorcontrib><creatorcontrib>Majidpoor, Jamal</creatorcontrib><creatorcontrib>Moradi, Fatemeh</creatorcontrib><creatorcontrib>Kasbiyan, Hamidreza</creatorcontrib><title>Olfactory mucosa stem cells delivery via nasal route: a simple way for the treatment of Parkinson disease</title><title>Neurotoxicity research</title><addtitle>Neurotox Res</addtitle><addtitle>Neurotox Res</addtitle><description>Finding a simple and effective way for transferring cells to the brain lesion site with minimum side effects mounts a challenge in cell therapy. Cell delivery via nasal route using the bypassing the blood-brain barrier (BBB) property is a simple and non-invasive strategy without serious complications such as trauma. Therefore, it is a suitable technique to treat neurodegenerative disorders like Parkinson’s disease (PD). Olfactory ectomesenchymal stem cells (OE-MSCs) located in the lamina propria of olfactory mucosa could be differentiated into dopaminergic neurons under
in vitro
and
in vivo
conditions. Thus, OE-MSCs represent a good source of Parkinson’s stem cell–based therapy. In this research, we studied thirty male rats (
n
= 10 in each group) in three control (Ctl), lesion (LE), and intranasal administration (INA) groups to investigate the therapeutic effect of intranasal injection of OE-MSCs in the Parkinson’s animal models. To do so, we examined the homing variation of OE-MSCs in different brain regions such as olfactory bulb (OB), cortex, striatum (Str), hippocampus (HPC), and substantia nigra (SN). The results of real-time PCR and immunohistochemistry (IHC) analysis showed the expression of dopaminergic neuron markers such as PITX3, PAX2, PAX5 (as dopaminergic neurons markers), tyrosine hydroxylase (TH), and dopamine transporter (DAT) 2 months after INA of 1 × 10
6
OE-MSCs. The results confirmed that IN OE-MSCs delivery into the central nervous system (CNS) was powerful enough to improve the behavioral functions in the animal models of PD.
Graphical Abstract</description><subject>Biomedical and Life Sciences</subject><subject>Biomedicine</subject><subject>Cell Biology</subject><subject>Neurobiology</subject><subject>Neurochemistry</subject><subject>Neurology</subject><subject>Neurosciences</subject><subject>Original Article</subject><subject>Pharmacology/Toxicology</subject><issn>1029-8428</issn><issn>1476-3524</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNp9kMtOwzAQRS0EoqXwAyyQfyDgV-2EHap4SZXKAtaW64whJYkr2ynq32MIsGQxmtHMvVeag9A5JZeUEHUVKZOCFITlIqwiBT1AUyqULPicicM8521RClZO0EmMmyyic6mO0YRzwbkq6RQ1q9YZm3zY426wPhocE3TYQttGXEPb7CCfdo3BvYmmxcEPCa5xljXdtgX8YfbY-YDTG-AUwKQO-oS9w08mvDd99D2umwgmwik6cqaNcPbTZ-jl7vZ58VAsV_ePi5tlYblQqWCKO2nAEGBqXa2tksLKygmlgJU1dyWhlXPAiKisIMwBpYI7xYhylbS05jPExlwbfIwBnN6GpjNhrynRX9z0yE1nbvqbm6bZdDGatsO6g_rP8gsqC_goiPnUv0LQGz-EPj_yX-wnvpB5rA</recordid><startdate>20210601</startdate><enddate>20210601</enddate><creator>Simorgh, Sara</creator><creator>Alizadeh, Rafieh</creator><creator>Shabani, Ronk</creator><creator>Karimzadeh, Fariba</creator><creator>Seidkhani, Elham</creator><creator>Majidpoor, Jamal</creator><creator>Moradi, Fatemeh</creator><creator>Kasbiyan, Hamidreza</creator><general>Springer US</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><orcidid>https://orcid.org/0000-0001-9231-280X</orcidid></search><sort><creationdate>20210601</creationdate><title>Olfactory mucosa stem cells delivery via nasal route: a simple way for the treatment of Parkinson disease</title><author>Simorgh, Sara ; Alizadeh, Rafieh ; Shabani, Ronk ; Karimzadeh, Fariba ; Seidkhani, Elham ; Majidpoor, Jamal ; Moradi, Fatemeh ; Kasbiyan, Hamidreza</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c347t-273f6aea0e27b9bc764c69f477e28d3f8019ffe2049c402fe1143f7207f96c1d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Biomedical and Life Sciences</topic><topic>Biomedicine</topic><topic>Cell Biology</topic><topic>Neurobiology</topic><topic>Neurochemistry</topic><topic>Neurology</topic><topic>Neurosciences</topic><topic>Original Article</topic><topic>Pharmacology/Toxicology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Simorgh, Sara</creatorcontrib><creatorcontrib>Alizadeh, Rafieh</creatorcontrib><creatorcontrib>Shabani, Ronk</creatorcontrib><creatorcontrib>Karimzadeh, Fariba</creatorcontrib><creatorcontrib>Seidkhani, Elham</creatorcontrib><creatorcontrib>Majidpoor, Jamal</creatorcontrib><creatorcontrib>Moradi, Fatemeh</creatorcontrib><creatorcontrib>Kasbiyan, Hamidreza</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><jtitle>Neurotoxicity research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Simorgh, Sara</au><au>Alizadeh, Rafieh</au><au>Shabani, Ronk</au><au>Karimzadeh, Fariba</au><au>Seidkhani, Elham</au><au>Majidpoor, Jamal</au><au>Moradi, Fatemeh</au><au>Kasbiyan, Hamidreza</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Olfactory mucosa stem cells delivery via nasal route: a simple way for the treatment of Parkinson disease</atitle><jtitle>Neurotoxicity research</jtitle><stitle>Neurotox Res</stitle><addtitle>Neurotox Res</addtitle><date>2021-06-01</date><risdate>2021</risdate><volume>39</volume><issue>3</issue><spage>598</spage><epage>608</epage><pages>598-608</pages><issn>1029-8428</issn><eissn>1476-3524</eissn><abstract>Finding a simple and effective way for transferring cells to the brain lesion site with minimum side effects mounts a challenge in cell therapy. Cell delivery via nasal route using the bypassing the blood-brain barrier (BBB) property is a simple and non-invasive strategy without serious complications such as trauma. Therefore, it is a suitable technique to treat neurodegenerative disorders like Parkinson’s disease (PD). Olfactory ectomesenchymal stem cells (OE-MSCs) located in the lamina propria of olfactory mucosa could be differentiated into dopaminergic neurons under
in vitro
and
in vivo
conditions. Thus, OE-MSCs represent a good source of Parkinson’s stem cell–based therapy. In this research, we studied thirty male rats (
n
= 10 in each group) in three control (Ctl), lesion (LE), and intranasal administration (INA) groups to investigate the therapeutic effect of intranasal injection of OE-MSCs in the Parkinson’s animal models. To do so, we examined the homing variation of OE-MSCs in different brain regions such as olfactory bulb (OB), cortex, striatum (Str), hippocampus (HPC), and substantia nigra (SN). The results of real-time PCR and immunohistochemistry (IHC) analysis showed the expression of dopaminergic neuron markers such as PITX3, PAX2, PAX5 (as dopaminergic neurons markers), tyrosine hydroxylase (TH), and dopamine transporter (DAT) 2 months after INA of 1 × 10
6
OE-MSCs. The results confirmed that IN OE-MSCs delivery into the central nervous system (CNS) was powerful enough to improve the behavioral functions in the animal models of PD.
Graphical Abstract</abstract><cop>New York</cop><pub>Springer US</pub><pmid>33433781</pmid><doi>10.1007/s12640-020-00290-1</doi><tpages>11</tpages><orcidid>https://orcid.org/0000-0001-9231-280X</orcidid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1029-8428 |
ispartof | Neurotoxicity research, 2021-06, Vol.39 (3), p.598-608 |
issn | 1029-8428 1476-3524 |
language | eng |
recordid | cdi_crossref_primary_10_1007_s12640_020_00290_1 |
source | Springer Nature |
subjects | Biomedical and Life Sciences Biomedicine Cell Biology Neurobiology Neurochemistry Neurology Neurosciences Original Article Pharmacology/Toxicology |
title | Olfactory mucosa stem cells delivery via nasal route: a simple way for the treatment of Parkinson disease |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T00%3A39%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Olfactory%20mucosa%20stem%20cells%20delivery%20via%20nasal%20route:%20a%20simple%20way%20for%20the%20treatment%20of%20Parkinson%20disease&rft.jtitle=Neurotoxicity%20research&rft.au=Simorgh,%20Sara&rft.date=2021-06-01&rft.volume=39&rft.issue=3&rft.spage=598&rft.epage=608&rft.pages=598-608&rft.issn=1029-8428&rft.eissn=1476-3524&rft_id=info:doi/10.1007/s12640-020-00290-1&rft_dat=%3Cpubmed_cross%3E33433781%3C/pubmed_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c347t-273f6aea0e27b9bc764c69f477e28d3f8019ffe2049c402fe1143f7207f96c1d3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/33433781&rfr_iscdi=true |